Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$57.44 USD
-19.06 (-24.92%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $58.16 +0.72 (1.25%) 5:00 PM ET
5-Strong Sell of 5 5
B Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MLAB 57.44 -19.06(-24.92%)
Will MLAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MLAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLAB
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Mettler-Toledo (MTD) Q2 Earnings and Revenues Top Estimates
MLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
Steris (STE) Surpasses Q4 Earnings Estimates
Other News for MLAB
12 Health Care Stocks Moving In Tuesday's Intraday Session
MLAB Reports Q1 Revenue Below Expectations Amid Economic Challenges
Mesa Labs Announces First Quarter Results | MLAB Stock News
Mesa Laboratories Inc (MLAB) Q1 Earnings: EPS of $0.85 Surpasses Estimates, Revenue at $59. ...
Mesa Laboratories GAAP EPS of $0.85 beats by $0.41, revenue of $59.54M misses by $1.03M